Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

NCT00051909 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00051909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00051909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
June 30, 2003
Enrollment
200
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease